Fairchem Organics Approves Buyback of Upto 4,25,000 Equity Shares at ₹800 Per Share

On November 20, 2025, the Board of Fairchem Organics approved buying back up to 4,25,000 fully paid equity shares priced at ₹800 each. This represents 3.26% of the company’s paid-up equity share capital.
The buyback will be carried out through a tender offer on a proportionate basis. As per regulations, 15% of the buyback entitlement or the entitlement for small shareholders, whichever is higher, will be reserved for them.
Financial Scope and Reserved Allocation
The buyback size is capped at ₹34 crore, excluding associated transaction costs. These costs may include brokerage, taxes, filing fees, stamp duty and communication expenses. Based on the company’s audited financial statements as of March 31, 2025, the buyback reflects 16% of the combined paid-up share capital and free reserves.
Read More: Infosys Share Price in Focus; Announces ₹18,000-Crore Share Buyback Opening Tomorrow, Nov 20!
Regulatory Requirements and Additional Approvals
The proposal requires shareholder approval via a special resolution through postal ballot and remote e-voting. The company will release further details including record date, process and timelines in compliance with SEBI’s buyback regulations. A buyback committee has also been constituted to manage and execute all related activities.
Promoter Participation and Appointment of Advisors
The promoters and promoter group of Fairchem Organics have expressed their intention not to participate in the buyback. Motilal Oswal Investment Advisors has been appointed as the manager to the buyback, while Parikh Dave and Associates will oversee the scrutiny of the postal ballot and e-voting process.
Fairchem Organics Share Price Performance
As of November 20, 2025, at 3:30 PM, Fairchem Organics share price was closed at ₹697.05 up by 0.33% from the previous closing price.
Conclusion
The buyback announcement of Fairchem Organics reflects a corporate decision focused on capital allocation within regulatory parameters. Final shareholding changes will be disclosed once the buyback process concludes.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 20, 2025, 4:03 PM IST

Team Angel One
- Adani Defence Signs Five-Year Ammunition Supply Agreement for AK-203 Programme
- AstraZeneca Gains FDA Approval for Camizestrant Combo in ESR1-Mutated Advanced Breast Cancer
- CBI Files FIR Against Subhash Chandra Over LIC Housing Finance Loan Fraud Allegations
- Top Gainers and Losers on September 3, 2026: Adani Ports, Axis Bank and HDFC Bank Rise Up to 2%
- Hilton Expands India Presence With 60 Hotels Under Construction, Plans 400 More Properties


